A phase 3 study to evaluate the efficacy and safety of induction and maintenace regimes of brodalumab compared with placebo and ustekinumab in subjects with moderate to severe plaque psoriasis: AMAGIN

  • Su, John (Primary Chief Investigator (PCI))

Project: Research

StatusFinished
Effective start/end date1/06/1230/05/16